Results 41 to 50 of about 1,439 (152)

Evaluation of prognostic value of MEDS, MEWS, and CURB‐65 criteria and sepsis I and sepsis III criteria in patients with community‐acquired infection in emergency department

open access: yesHong Kong Journal of Emergency Medicine, Volume 27, Issue 5, Page 277-285, September 2020., 2020
Background: Early and effective treatment of patients with sepsis requires early recognition in emergency department and understanding the severity of the disease. Many studies have been conducted for this purpose, and many of scoring systems have been developed that provide early recognition of these patients and show their severity.
Maruf Beğenen   +3 more
wiley   +1 more source

Efficacy and Safety of Tedizolid and Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Injection Drug Users: Analysis of Two Clinical Trials

open access: yesInfectious Diseases and Therapy, 2018
Introduction Injection drug users (IDUs) often develop acute bacterial skin and skin structure infections (ABSSSI) and use emergency departments as their primary source for medical care.
Gregory J. Moran   +5 more
doaj   +1 more source

Outpatient care concept and potential inpatient cost savings associated with the administration of dalbavancin – A real-world data and retrospective cost analysis

open access: yesJournal of Infection and Public Health, 2023
Background: The treatment of acute bacterial skin and skin structure infections (ABSSSI) usually involves intravenous (i.v.) antibiotics requiring hospitalisation and increasing hospital costs.
Christoph T. Baltin   +10 more
doaj   +1 more source

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)

open access: yesJournal of Global Antimicrobial Resistance, 2020
Objectives: Delafloxacin is a broad-spectrum anionic fluoroquinolone with activity against Gram-positive and Gram-negative organisms, including methicillin-resistant Staphylococcus aureus.
Dee Shortridge   +3 more
doaj   +1 more source

Efficacy and safety of Delafloxacin in the treatment of Acute Bacterial Skin or Skin structure Infection (ABSSSI).

open access: yes
This project consists of a systematic review aiming to evaluate the efficacy and safety of delafloxacin for the treatment of acute bacterial skin and skin structure infections (ABSSSI) in adults.
Iani Lima Franco   +7 more
core   +6 more sources

The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) [PDF]

open access: yes, 2020
Introduction: Acute bacterial skin and skin-structure infections (ABSSSI) are a subgroup of skin and soft tissue infections and are a common source of morbidity in both the community and the hospital setting.
Pea F., Soriano A., Rossolini G. M.
core   +1 more source

Risk Factors for Bloodstream Infections Among an Urban Population with Skin and Soft Tissue Infections: A Retrospective Unmatched Case-Control Study

open access: yesInfectious Diseases and Therapy, 2018
Introduction The prevalence of acute bacterial skin and skin structure infections (ABSSSIs) continues to increase. Bloodstream infection (BSI) is a severe secondary complication of ABSSSI.
Michael J. Rybak   +6 more
doaj   +1 more source

Empiric treatment approach for the management of post-operative incisional infections with omadacycline

open access: yesFoot & Ankle Surgery: Techniques, Reports & Cases, 2023
: Background: Surgical wound dehiscence (SWD) is one of the most common complications of surgical incision sites after foot surgeries because of blood flow and circulation issues that may occur in the foot. Such SWD complications can potentially lead to
Philip Wrotslavsky
doaj   +1 more source

Acute bacterial skin and skin structure infections: current perspective

open access: yesIndian Journal of Dermatology, 2011
A skin and skin structure infection is a bacterial infection of skin and associated tissues. It may be complicated skin and skin structure infection or uncomplicated skin and skin structure infection. Recently, the Food and Drug Administration has called
Megha Shah, Hetal D Shah
doaj   +1 more source

Innovative Wirkstoffe aus der antibakteriellen Forschung im Kampf gegen mikrobielle Resistenzen

open access: yesAngewandte Chemie, Volume 137, Issue 10, March 3, 2025.
Dieser Artikel gewährt einen Überblick über in den letzten drei Jahrzehnten untersuchte antibakteriellen Wirkstoffe. Aspekte der Herkunft, der zellulären Targetstrukturen, des antibakteriellen Wirkspektrums und dem Nachweis der Wirksamkeit in Tierstudien werden zusammen mit aktuellen Entwicklungen beleuchtet.
Roderich D. Süssmuth   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy